`
`
`
`Filed: November 27, 2017
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________________
`
`
`MYLAN PHARMACEUTICALS INC.,
`TEVA PHARMACEUTICALS USA, INC. and AKORN INC.,1
`Petitioner,
`
`v.
`
`ALLERGAN, INC.
`Patent Owner.
`
`_____________________________
`
`Case IPR2016-01127 (US 8,685,930 B2)
`Case IPR2016-01128 (US 8,629,111 B2)
`Case IPR2016-01129 (US 8,642,556 B2)
`Case IPR2016-01130 (US 8,633,162 B2)
`Case IPR2016-01131 (US 8,648,048 B2)
`Case IPR2016-01132 (US 9,248,191 B2)
`_____________________________
`
`PETITIONER’S NOTICE OF OBJECTION TO EVIDENCE
`
`
`1 Cases IPR2017-00576 and IPR2017-00594, IPR2017-00578 and IPR2017-
`00596, IPR2017-00579 and IPR2017-00598, IPR2017-00583 and IPR2017-00599,
`IPR2017-00585 and IPR2017-00600, and IPR2017-00586 and IPR2017-00601,
`have respectively been joined with the captioned proceedings. The word-for-word
`identical paper is filed in each proceeding identified in the caption pursuant to the
`Board’s Scheduling Order (Paper 10).
`
`
`
`
`
`
`
`
`
`TABLE OF CONTENTS
`
`INTRODUCTION ........................................................................................ 1
`I.
`OBJECTIONS .............................................................................................. 1
`II.
`1.
`Thereon ..................................................................................... 1
`III. CONCLUSION ............................................................................................ 3
`
`Objections to EX2113, and any Reference to/Reliance
`
`
`
`
`-i-
`
`
`
`
`
`I.
`
`INTRODUCTION
`
`Pursuant to 37 C.F.R. § 42.64(b)(1), Petitioner submits the following
`
`objections to Exhibits 2113 as listed on each List of Exhibits filed by the St. Regis
`
`Mohawk Tribe (“Tribe”) on November 17, 2017, and any reference to or reliance
`
`on the foregoing Exhibits in Tribe’s filings. As required by 37 C.F.R. §42.62,
`
`Petitioner’s objections below apply the Federal Rules of Evidence (“F.R.E.”).
`
`II. OBJECTIONS
`1. Objections to EX2113, and any Reference to/Reliance Thereon
`
`Grounds for Objection: F.R.E. 106 (incomplete); F.R.E. 402 (relevance);
`
`403 (prejudice); F.R.E. 603 (unsworn testimony); F.R.E. 801, 802, 803, 805
`
`(inadmissible hearsay); F.R.E. 901 (authenticity).
`
`Tribe describes EX2113 as “Excerpts of Chief Judge David Rushke’s
`
`Testimony at 11/09/17 PPAC Quarterly Meeting.” Tribe filed EX2113 on
`
`November 17, 2017 without first contacting Petitioners to meet and confer and
`
`without authorization from the Board to make a supplemental filing or to submit
`
`supplemental information. As far as Petitioners are aware, Tribe failed to even
`
`request authorization for such a filing. Tribe also failed to satisfy the requirements
`
`for submitting supplemental information.
`
`Tribe’s own description of EX2113 indicates that Tribe submitted only
`
`excerpts of the “testimony,” which partial transcript contains many errors. The
`
`
`-1-
`
`
`
`transcript also does not purport to be a complete transcription of the excerpts
`
`included, but merely a “computer transcription” of those sections. For these
`
`reasons, the document is incomplete under F.R.E. 106 and inadmissible.
`
`EX2113 lacks relevance to the instituted grounds of the petitions and the
`
`merits of these proceedings. EX2113 is also riddled with errors. To give just two
`
`examples, the document refers repeatedly to remands of patent cases to the PTAB
`
`from the “Fifth Circuit,” and the PTAB being “as religious as possible.” The lack
`
`of relevance and likelihood of prejudice and waste of time from this incomplete
`
`and error-filled transcript each justify exclusion of the exhibit under F.R.E. 402-
`
`403.
`
`Tribe characterizes EX2113 as containing a partial account of “testimony”
`
`given outside the present proceedings. However, Tribe offers no evidence that
`
`EX2113 contains testimony of any kind, much less testimony complying with the
`
`oath or affirmation requirements of F.R.E. 603. The word “testimony” does not
`
`even appear in EX2113 itself. Moreover, EX2113 and any assertions contained
`
`therein are inadmissible hearsay when offered for the truth of the matter asserted.
`
`F.R.E. 801, 802, 803, 805. Tribe also fails to offer competent evidence
`
`authenticating the statements contained in EX2113 as the statements of the
`
`purported declarant. F.R.E. 901.
`
`-2-
`
`
`
`III. CONCLUSION
`
`Exhibit 2113 should be stricken as an unauthorized filing and should be
`
`excluded from evidence if not stricken for the reasons stated above.
`
`
`
`Dated: November 27, 2017
`
`
`
`
`
`Respectfully submitted,
`
`/ Steven W. Parmelee /
` Steven W. Parmelee
` Reg. No. 31,990
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`-3-
`
`
`
`CERTIFICATE OF SERVICE
`
`
`
`This is to certify that I caused to be served a true and correct copy of the
`
`foregoing Petitioners’ Notice of Objection to Evidence, on this 27th day of
`
`November, 2017, on Allergan and St. Regis Mohawk Tribe at the correspondence
`
`address of Allergan and St. Regis Mohawk Tribe as follows:
`
`Dorothy P. Whelan
`Michael Kane
`Susan Morrison Colletti
`Robert M. Oakes
`Jonathan Singer
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Email: IPR13351-0008IP1@fr.com
`Email: IPR13351-0008IP2@fr.com
`Email: IPR13351-0008IP3@fr.com
`Email: IPR13351-0008IP4@fr.com
`Email: IPR13351-0008IP5@fr.com
`Email: IPR13351-0008IP6@fr.com
`Email: PTABInbound@fr.com
`
`
`Alfonso Chan
`Joseph DePumpo
`Michael W. Shore
`Christopher L. Evans
`Shore Chan DePumpo LLP
`901 Main Street, Suite 3300
`Dallas, TX 75201
`Email: achan@shorechan.com
`Email: jdepumpo@shorechan.com
`Email: mshore@shorechan.com
`Email: cevans@shorechan.com
`
`
`-4-
`
`
`
`Marsha K. Schmidt
`14928 Perrywood Drive
`Burtonsville, MD 20866
`Email: marsha@mkschmidtlaw.com
`
`And on the remaining petitioners as follows:
`
`
`Gary Speier
`Mark Schuman
`CARLSON, CASPERS, VANDENBURGH,
`LINDQUIST & SCHUMAN, P.A.
`225 South Sixth Street, Suite 4200
`Minneapolis, MN 55402
`Email: gspeier@carlsoncaspers.com
`Email: mschuman@carlsoncaspers.com
`Attorneys for Teva Pharmaceuticals USA, Inc.
`
`
`Michael Dzwonczyk
`Azadeh Kokabi
`Travis Ribar
`SUGHRUE MION, PLLC
`2100 Pennsylvania Ave., NW
`Washington, DC 20037
`Email: mdzwonczyk@sughrue.com
`Email: akokabi@sughrue.com
`Email: tribar@sughrue.com
`Attorneys for Akorn Inc.
`
`
`
`Dated: November 27, 2017
`
`
`
`
`
`
`Respectfully submitted,
`
`/ Steven W. Parmelee /
` Steven W. Parmelee, Lead Counsel
` Reg. No. 31,990
`
`
`
`
`
`-5-
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
